If you’ve been trying to control ulcerative colitis (UC), you’re probably looking forward to the day your doctor says you’re in remission. “When you start UC treatment, the first goal is just … to ...

Since your ulcerative colitis (UC) diagnosis, you did everything your doctor told you to do — took your medication as prescribed, watched what you ate, and managed your stress. And you started to feel ...

DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...

DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a months-long bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...

DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...

DEAR DR. ROACH: I am a 64-year-old female who is in moderate health. After a monthslong bout of diarrhea, blood work, and a colonoscopy, I’ve been diagnosed with microscopic colitis. After a round of ...

Natasha Lyonne revealed she recently relapsed after decades of sobriety: “Took my relapse public more to come,” the actress wrote on social media Friday. “Recovery is a lifelong process. Anyone out ...

Natasha Lyonne — who battled drug and alcohol addictions in the mid-2000s — revealed she’s no longer sober in a candid social media post. “Took my relapse public more to come,” she wrote via X on ...

Natasha Lyonne has relapsed after nearly a decade of sobriety. “Took my relapse public, more to come,” Lyonne, 46, wrote via X on Friday, January 23, shortly before responding to a fan sending the ...

Lymphocytic colitis is a bowel condition characterized by chronic, watery diarrhea and the buildup of white blood cells in your gut. It is most common in older adults. Lymphocytic colitis is a rare ...

MRD-guided retreatment with anti-CD20 antibodies may improve survival outcomes in high-risk, relapsed CLL patients by initiating therapy before clinical relapse. The study showed MRD-triggered ...